For a complete list of research studies, including those currently recruiting subjects, click here to visit the home page of each of the IOL's four Research Centers.
For a list of ongoing clinical trials in the area of psychiatry, click here.
Click here for Hartford Hospital trials listed on the clinicaltrials.gov website.
The research studies listed below are currently recruiting volunteers to participate.
 
For each study there is a brief description and contact information.

 


Attention Deficit Hyperactivity Disorder (ADHD) in Adults

The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 18-55 years of age for a 12-month, open-label treatment with study medication SEP-225289 as a treatment for adults with ADHD.

For more information about this trial, please contact: 

Dr. John W. Goethe and Dr. Andrew Winokur
phone: (860) 545-7502
email: clinical.trials@hhchealth.org

 (top


Bipolar Disorder in Pediatric and Adolescents (depressive episode)

The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 10-17 years of age for a clinical trial testing the safety and efficacy of Lurasidone treatment study in pediatric and adolescent depression associated with Bipolar I Disorder. All subjects who complete the 6-week study are eligible for a 104 week open-label flexible-dose trial of Lurasidone.

For more information about this trial, please contact: 

Dr. Salma Malik
phone: (860) 545-7502
email: clinical.trials@hhchealth.org

Bipolar Disorder in Pediatric and Adolescents (manic episode)

The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 10-17 years of age for a 4-week, double-blind, clinical trial using Ziprasidone treatment study in pediatric and adolescent mania associated with Bipolar I Disorder.

For more information about this trial, please contact: 

Dr. Salma Malik
phone: (860) 545-7502
email: clinical.trials@hhchealth.org

 (top)


Child & Adolescent Research 

Click here to visit the Child & Adolescent Research  research webpage.
 
 
 
(top)

Compulsive Hoarding

The Anxiety Disorders Center is currently recruiting adults ages 20 - 60 who struggle with excessive clutter for a cognitive-behavioral treatment research study.

Click here for further information, including contact information.
 
(top)

Depression in Pediatric and Adolescents

The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 7-17 years of age for a double-blind, clinical trial using Desvenlafaxine for the treatment of pediatric and adolescent major depressive disorder. All subjects who complete the 8-week study are eligible for a 6-month open-label flexible-dose trial of Desvenlafaxine.

For more information about this trial, please contact: 

Dr. Salma Malik
phone: (860) 545-7502
email: clinical.trials@hhchealth.org

 (top)


Neuroimaging Studies

The Olin Neuropsychiatry Research Center is at the forefront of research in applying quantitative measures of brain structure and function to neuropsychiatric themes, especially to severe mental illnesses, such as schizophrenia.  Techniques include structural and functional MRI.  In addition, electrophysiologic measures, including event-related potential assessments, are an important feature of our research.

To learn more about the studies currently being conducted, click here
or contact:
Rosalynn Walker
phone: (860) 545-7800
email: Rosalynn.Walker@hhchealth.org
(top)

Panic Disorder

The Anxiety Disorders Center is currently recruiting adults ages 18 - 65 with panic disorder for a treatment study.

 
(top)   


Postpartum Depression

The Burlingame Center for Psychiatric Research and Education is currently recruiting female patients 18 - 50 years of age for a clinical trial using an alternative treatment for postpartum depression called transcranial magnetic stimulation (TMS).

For more information about this trial, please contact: 

Dr. John W. Goethe
phone: (860) 545-7502
email: clinical.trials@hhchealth.org

 (top)


Schizophrenia in Adolescents

The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 13-17 years of age for a clinical trial testing the safety and efficacy of Lurasidone treatment for adolescents with schizophrenia. All subjects who complete the 6-week double-blind study are eligible for a 104 week open-label flexible-dose trial of Lurasidone.

For more information about this trial, please contact: 

Dr. Salma Malik
phone: (860) 545-7502
email: clinical.trials@hhchealth.org

Schizophrenia in Adolescents (add-on medication)

The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 12-16 years of age for a 6-week, double-blind, clinical trial with, NaBen, as an add-on treatment study in pediatric and adolescent Schizophrenia.

For more information about this trial, please contact: 

Dr. John W. Goethe
phone: (860) 545-7502
email: clinical.trials@hhchealth.org

 (top


Sertraline Pediatric Registry (SPRITES)

This non-interventional study will examine the risks and benefits of up to 3 years of treatment with sertraline on cognition, emotional and physical development, and pubertal maturation in children ages 6 to 14 years. Recruitment Needs: Patients ages 6-14 diagnosed with an anxiety or depressive disorder that are starting sertraline or starting therapy but not taking sertraline, with an IOL psychiatrist or psychologist. This study will not alter treatment regimen.

For more information about this trial, please contact: 

Dr. Salma Malik
phone: (860) 545-7502
email: clinical.trials@hhchealth.org

 (top